Amia Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-15,205
Closed -$910K 48
2019
Q4
$910K Buy
+15,205
New +$571K 0.27% 28

Amia Capital's BOLD Position: Q1 2020 in Review

Amia Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 15,205 shares — an estimated $910K sold.

Amia Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $910K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Amia Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Amia Capital sold 15,205 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $910K.
  • Amia Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Amia Capital's Audentes Therapeutics, Inc position peaked at $910K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Amia Capital's 13F filing for Q1 2020, filed 15 May 2020.